Chronic rhinosinusitis (CRS) is an inflammatory disorder of the paranasal sinuses and the nasal cavity lasting longer than 12 weeks. This disease is a common clinical syndrome with significant monetary burden due to the high costs of medical visits, diagnostic tests, medications, and surgical therapies. CRS without nasal polyposis (CRSsNP) is the most common subtype of CRS, accounting for about 70% of all patients. Other subtypes include CRS with nasal polyposis (CRSwNP) and allergic fungal rhinosinusitis (AFRS). CRSwNP has the worldwide prevalence of 2% to 4% and is often accompanied by type 2 inflammation and asthma as a comorbid condition. Pediatric chronic sinusitis is distinct from adult chronic sinusitis and is currently considered an infectious process, characterized by persistent inflammation representing an exaggerated immune response to an external stimulus. The medical and surgical management of CRS has been remarkably modified in the past two decades. The aim of this study was to present an update on CRS based on the recent years’ literature.
Background: The landscape of aesthetic medicine has increasingly favored minimally invasive interventions, with the 1470 nm diode laser (Endolift) gaining prominence as a viable alternative to surgical lifting for soft‐tissue remodeling and lipolysis. Aims: This narrative review synthesizes current evidence on the mechanism, clinical versatility, and safety profile of Endolift. A primary objective is to evaluate the synergistic potential of combining this technology with complementary aesthetic modalities to optimize patient outcomes. Patients/Methods: A comprehensive search of PubMed/MEDLINE, Scopus, and Google Scholar was conducted. We analyzed key literature on the 1470 nm diode laser, selecting studies that document its efficacy as monotherapy and in combination with injectables or regenerative techniques. Results: The 1470 nm wavelength exhibits high affinity for water, facilitating selective lipolysis and stimulating deep collagen restructuring through controlled photothermal interaction. Clinical findings consistently report tangible improvements in skin laxity and contouring with limited recovery time. Notably, multimodal protocols—integrating dermal fillers, nanofat, or surface resurfacing—appear to enhance aesthetic outcomes by simultaneously addressing volume deficits and superficial texture alongside tissue tightening. Conclusions: Endolift represents a robust, minimally invasive tool for facial and body sculpting. While current data support its efficacy, particularly within multimodal treatment plans, the standardization of protocols through larger, randomized controlled trials remains a priority to confirm long‐term durability.
The combination of Endolift laser therapy and injectable platelet‐rich fibrin (i‐PRF) is an emerging strategy in aesthetic medicine, but the optimal scheduling of these modalities remains unexplored. This case report highlights a novel treatment schedule combining i‐PRF and Endolift laser therapy, resulting in noticeable short‐term facial rejuvenation in a 56‐year‐old female. A 56‐year‐old woman presented with concerns regarding facial skin laxity and aging. A unique treatment schedule was implemented: i‐PRF injections were administered 1 day before (Day −1), 1 week after (Day +7), and 1 month after (Day +30) a single Endolift laser session (Day 0). At the 4‐week follow‐up, the patient demonstrated marked improvement in skin tightness, texture, and overall facial appearance, as assessed by clinical examination, standardized photography, and high patient‐reported satisfaction. Only mild, transient adverse effects were observed, with no delayed complications. This novel schedule combining i‐PRF and the Endolift laser demonstrates promising synergistic effects, resulting in significant short‐term skin rejuvenation. While these initial findings suggest that the precise timing of i‐PRF enhances the regenerative impact of Endolift therapy, further large‐scale studies utilizing objective measurement scales and extended follow‐up periods (3–6 months) are warranted to validate long‐term durability and establish standardized protocols.
Case: A 15-year-old male patient diagnosed with arthrogryposis presented with a left knee extension contracture. He underwent an innovative percutaneous quadricepsplasty performed arthroscopically. Subsequent to the procedure, the patient was enrolled in an aggressive physiotherapy program. Over a follow-up period of 12 months, significant improvement was observed, with the patient achieving a 95° range of motion in his left knee. Conclusion: Noninvasive percutaneous quadricepsplasty, combined with methods such as arthroscopy, may enhance therapeutic outcomes and alleviate chronic knee extension contractures in patients with arthrogryposis. This combination of treatment methods has the potential to revolutionize the management of such conditions.
Lichen planus (LP) is a chronic inflammatory scalp disorder that can lead to cicatricial alopecia, making it challenging for hair transplantation. This case report describes a 26‐year‐old female with LP who underwent scalp preparation using SVF and PRF before hair transplantation. SVF was administered 6 weeks prior, followed by PRF 4 weeks before the procedure to enhance scalp vascularization and reduce inflammation. After 1 year of follow‐up, significant graft survival and improved scalp condition were observed without major complications. This report highlights the potential of SVF and PRF in optimizing hair transplantation outcomes for patients with LP.